Substance use disorder (SUD) treatment executives are largely optimistic that COVID-era telehealth prescribing flexibilities, set to expire in December 2024, will be made permanent. But information released from a Drug Enforcement Administration (DEA) insider and published in Politico Pro in the days since SUD executives spoke with Addiction Treatment Business…